Latest Intelligence on Pharmaceuticals and Healthcare in Turkey

Published within

« | 1 | » »|

Type Product title / description Pub Price
Expert View
Expert View

Big Pharma rushing for foothold in emerging markets despite challenges

Faced with dwindling growth rates in the US and Europe, drug companies are turning their attention towards emerging pharmaceutical markets where recent economic booms have fuelled double-digit growth. However, although the patient potential of these countries is enormous, foreign pharmaceutical companies are currently tapping into only a fraction of the market.

Published By Datamonitor
13 Mar 2008
CommentWire
CommentWire

Pharmaceuticals: facing a Greek tragedy

With the passing of Greece's latest austerity measures, healthcare spending is set to be reduced by a reported E2.1bn ($2.8bn) during 2011-15, primarily through price cuts on pharmaceuticals. This will negatively impact pharmaceutical company sales not only in that nation, but also in other countries that reference Greek drug prices.

Published By Datamonitor
30 Jun 2011

« | 1 | » »|

No help is available.